Concepts (191)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Laryngeal Muscles | 6 | 2015 | 17 | 2.360 |
Why?
|
| Muscular Atrophy | 6 | 2015 | 76 | 1.360 |
Why?
|
| Aging | 7 | 2017 | 955 | 1.190 |
Why?
|
| Deglutition | 4 | 2017 | 30 | 1.050 |
Why?
|
| Muscle, Skeletal | 8 | 2016 | 537 | 1.010 |
Why?
|
| Ubiquitin-Protein Ligases | 3 | 2015 | 43 | 0.900 |
Why?
|
| Muscle Proteins | 3 | 2015 | 64 | 0.900 |
Why?
|
| Hyoid Bone | 2 | 2015 | 5 | 0.870 |
Why?
|
| Carcinoma, Adenoid Cystic | 2 | 2017 | 7 | 0.650 |
Why?
|
| Salivary Gland Neoplasms | 2 | 2017 | 13 | 0.650 |
Why?
|
| Deglutition Disorders | 3 | 2017 | 52 | 0.620 |
Why?
|
| MicroRNAs | 2 | 2017 | 190 | 0.550 |
Why?
|
| Respiratory Aspiration | 2 | 2017 | 21 | 0.540 |
Why?
|
| Acute Lung Injury | 2 | 2015 | 37 | 0.520 |
Why?
|
| Cesium Radioisotopes | 1 | 2015 | 5 | 0.470 |
Why?
|
| Gamma Rays | 1 | 2015 | 25 | 0.470 |
Why?
|
| Muscle Contraction | 2 | 2017 | 113 | 0.460 |
Why?
|
| Animals | 17 | 2017 | 7599 | 0.440 |
Why?
|
| Rats | 9 | 2014 | 1610 | 0.400 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2013 | 134 | 0.390 |
Why?
|
| Pharyngeal Muscles | 1 | 2012 | 5 | 0.390 |
Why?
|
| Neuromuscular Junction | 2 | 2017 | 66 | 0.380 |
Why?
|
| Myosin Heavy Chains | 2 | 2012 | 89 | 0.380 |
Why?
|
| Levodopa | 1 | 2012 | 15 | 0.380 |
Why?
|
| Reflex | 1 | 2012 | 16 | 0.380 |
Why?
|
| Dopamine Agents | 1 | 2012 | 20 | 0.370 |
Why?
|
| Quadriceps Muscle | 1 | 2012 | 33 | 0.360 |
Why?
|
| Extremities | 1 | 2012 | 54 | 0.360 |
Why?
|
| Sprains and Strains | 3 | 2005 | 11 | 0.330 |
Why?
|
| Male | 18 | 2017 | 19754 | 0.310 |
Why?
|
| Laryngeal Diseases | 1 | 2009 | 9 | 0.300 |
Why?
|
| Receptors, Dopamine D1 | 1 | 2009 | 18 | 0.300 |
Why?
|
| Rats, Sprague-Dawley | 6 | 2014 | 754 | 0.270 |
Why?
|
| Female | 14 | 2017 | 20375 | 0.260 |
Why?
|
| Motilin | 1 | 2007 | 1 | 0.260 |
Why?
|
| Gastrointestinal Motility | 1 | 2007 | 3 | 0.260 |
Why?
|
| Muscle Fibers, Fast-Twitch | 3 | 2017 | 28 | 0.250 |
Why?
|
| Amygdala | 1 | 2007 | 59 | 0.250 |
Why?
|
| Troponin T | 2 | 2017 | 95 | 0.230 |
Why?
|
| Wasting Syndrome | 2 | 2015 | 14 | 0.220 |
Why?
|
| Cumulative Trauma Disorders | 1 | 2004 | 12 | 0.220 |
Why?
|
| Lipid Peroxidation | 1 | 2004 | 32 | 0.220 |
Why?
|
| Ascorbic Acid | 1 | 2004 | 21 | 0.220 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 2004 | 17 | 0.210 |
Why?
|
| Estrogens | 1 | 2004 | 169 | 0.200 |
Why?
|
| Exercise Therapy | 2 | 2017 | 282 | 0.200 |
Why?
|
| Regeneration | 1 | 2004 | 170 | 0.200 |
Why?
|
| Disease Models, Animal | 4 | 2013 | 1015 | 0.190 |
Why?
|
| Lung Neoplasms | 2 | 2016 | 429 | 0.190 |
Why?
|
| Muscle Fibers, Skeletal | 2 | 2012 | 107 | 0.180 |
Why?
|
| Receptors, Dopamine D2 | 2 | 2014 | 78 | 0.170 |
Why?
|
| Laryngeal Nerves | 2 | 2012 | 5 | 0.170 |
Why?
|
| Mice | 3 | 2017 | 2529 | 0.170 |
Why?
|
| Cell Line, Tumor | 3 | 2017 | 727 | 0.170 |
Why?
|
| Humans | 12 | 2017 | 32968 | 0.160 |
Why?
|
| Young Adult | 3 | 2017 | 2738 | 0.150 |
Why?
|
| Chemokines | 2 | 2016 | 33 | 0.150 |
Why?
|
| Aged, 80 and over | 4 | 2017 | 4065 | 0.150 |
Why?
|
| Mice, Inbred C57BL | 3 | 2016 | 790 | 0.150 |
Why?
|
| Adult | 4 | 2017 | 9586 | 0.140 |
Why?
|
| Physical Conditioning, Animal | 2 | 2015 | 35 | 0.130 |
Why?
|
| Receptors, Retinoic Acid | 1 | 2017 | 9 | 0.130 |
Why?
|
| Oxidoreductases Acting on CH-CH Group Donors | 1 | 2017 | 9 | 0.130 |
Why?
|
| Age Factors | 3 | 2017 | 1202 | 0.130 |
Why?
|
| Salivary Glands | 1 | 2017 | 14 | 0.130 |
Why?
|
| Muscle Denervation | 1 | 2017 | 27 | 0.130 |
Why?
|
| Lipopolysaccharides | 2 | 2015 | 115 | 0.130 |
Why?
|
| Fetal Proteins | 1 | 2016 | 7 | 0.130 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2016 | 10 | 0.130 |
Why?
|
| T-Box Domain Proteins | 1 | 2016 | 14 | 0.130 |
Why?
|
| Aged | 6 | 2017 | 10637 | 0.130 |
Why?
|
| Nerve Tissue Proteins | 1 | 2017 | 117 | 0.130 |
Why?
|
| Receptors, Chemokine | 1 | 2016 | 11 | 0.120 |
Why?
|
| Muscle Fibers, Slow-Twitch | 2 | 2016 | 19 | 0.120 |
Why?
|
| Gait | 1 | 2017 | 140 | 0.120 |
Why?
|
| Gene Expression | 1 | 2017 | 336 | 0.120 |
Why?
|
| Calpain | 1 | 2016 | 13 | 0.120 |
Why?
|
| Immunoenzyme Techniques | 1 | 2015 | 43 | 0.120 |
Why?
|
| Sex Factors | 2 | 2017 | 684 | 0.120 |
Why?
|
| Calcium Channels, L-Type | 1 | 2016 | 45 | 0.120 |
Why?
|
| Linear Models | 2 | 2013 | 445 | 0.120 |
Why?
|
| Blotting, Western | 1 | 2015 | 290 | 0.110 |
Why?
|
| Posture | 1 | 2015 | 56 | 0.110 |
Why?
|
| Retrospective Studies | 2 | 2013 | 3708 | 0.110 |
Why?
|
| Neutrophils | 1 | 2015 | 110 | 0.110 |
Why?
|
| Vocal Cords | 1 | 2014 | 9 | 0.100 |
Why?
|
| Autoreceptors | 1 | 2014 | 9 | 0.100 |
Why?
|
| Tracheal Stenosis | 1 | 2013 | 5 | 0.100 |
Why?
|
| Amphetamine | 1 | 2014 | 37 | 0.100 |
Why?
|
| Observer Variation | 1 | 2013 | 96 | 0.100 |
Why?
|
| Mandible | 1 | 2013 | 39 | 0.100 |
Why?
|
| Trachea | 1 | 2013 | 52 | 0.100 |
Why?
|
| Reference Values | 1 | 2013 | 238 | 0.100 |
Why?
|
| Oxidative Stress | 2 | 2005 | 243 | 0.100 |
Why?
|
| Velopharyngeal Sphincter | 1 | 2012 | 4 | 0.100 |
Why?
|
| Dopamine Uptake Inhibitors | 1 | 2014 | 117 | 0.100 |
Why?
|
| Ultrasonography | 1 | 2015 | 381 | 0.090 |
Why?
|
| Mice, Knockout | 1 | 2014 | 458 | 0.090 |
Why?
|
| Databases, Protein | 1 | 2012 | 13 | 0.090 |
Why?
|
| Tongue | 1 | 2012 | 14 | 0.090 |
Why?
|
| Head | 1 | 2012 | 56 | 0.090 |
Why?
|
| Rats, Inbred F344 | 1 | 2012 | 134 | 0.090 |
Why?
|
| Species Specificity | 1 | 2012 | 89 | 0.090 |
Why?
|
| Protein Isoforms | 1 | 2012 | 59 | 0.090 |
Why?
|
| Stem Cell Transplantation | 1 | 2013 | 212 | 0.090 |
Why?
|
| Multivariate Analysis | 1 | 2013 | 682 | 0.090 |
Why?
|
| Mass Spectrometry | 1 | 2012 | 101 | 0.090 |
Why?
|
| Reconstructive Surgical Procedures | 1 | 2013 | 198 | 0.090 |
Why?
|
| Reaction Time | 1 | 2012 | 119 | 0.090 |
Why?
|
| Radiography | 1 | 2012 | 386 | 0.090 |
Why?
|
| Dopamine | 1 | 2014 | 234 | 0.090 |
Why?
|
| Reproducibility of Results | 1 | 2013 | 770 | 0.090 |
Why?
|
| Proteomics | 1 | 2012 | 102 | 0.090 |
Why?
|
| Muscle Strength | 1 | 2012 | 159 | 0.090 |
Why?
|
| Adiposity | 1 | 2012 | 199 | 0.080 |
Why?
|
| Cross-Sectional Studies | 1 | 2015 | 1581 | 0.080 |
Why?
|
| Salicylamides | 1 | 2009 | 4 | 0.080 |
Why?
|
| Obesity | 1 | 2017 | 1179 | 0.080 |
Why?
|
| Cohort Studies | 1 | 2013 | 1852 | 0.080 |
Why?
|
| Dopamine Antagonists | 1 | 2009 | 21 | 0.080 |
Why?
|
| Benzazepines | 1 | 2009 | 22 | 0.080 |
Why?
|
| Electromyography | 1 | 2009 | 60 | 0.070 |
Why?
|
| Electric Stimulation | 1 | 2009 | 106 | 0.070 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2013 | 950 | 0.070 |
Why?
|
| Time Factors | 2 | 2015 | 2195 | 0.070 |
Why?
|
| Risk Assessment | 1 | 2013 | 1469 | 0.070 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2009 | 622 | 0.070 |
Why?
|
| Receptors, Gastrointestinal Hormone | 1 | 2007 | 1 | 0.060 |
Why?
|
| Receptors, Neuropeptide | 1 | 2007 | 3 | 0.060 |
Why?
|
| Peptides, Cyclic | 1 | 2007 | 4 | 0.060 |
Why?
|
| Injections, Intraventricular | 1 | 2007 | 13 | 0.060 |
Why?
|
| Microinjections | 1 | 2007 | 35 | 0.060 |
Why?
|
| Electrophysiology | 1 | 2007 | 72 | 0.060 |
Why?
|
| Neoplasm Invasiveness | 2 | 2016 | 193 | 0.060 |
Why?
|
| Creatine Kinase | 1 | 2004 | 11 | 0.060 |
Why?
|
| Superoxide Dismutase | 1 | 2005 | 43 | 0.060 |
Why?
|
| Desmin | 1 | 2004 | 12 | 0.060 |
Why?
|
| Vitamin E | 1 | 2004 | 19 | 0.050 |
Why?
|
| Glutathione | 1 | 2004 | 45 | 0.050 |
Why?
|
| Vimentin | 1 | 2004 | 9 | 0.050 |
Why?
|
| Ovariectomy | 1 | 2004 | 162 | 0.050 |
Why?
|
| Antioxidants | 1 | 2004 | 116 | 0.050 |
Why?
|
| Oxidation-Reduction | 1 | 2004 | 269 | 0.050 |
Why?
|
| Random Allocation | 1 | 2004 | 229 | 0.050 |
Why?
|
| Neurons | 1 | 2007 | 417 | 0.050 |
Why?
|
| Immunohistochemistry | 1 | 2004 | 497 | 0.050 |
Why?
|
| Signal Transduction | 2 | 2016 | 689 | 0.040 |
Why?
|
| Laryngoscopy | 1 | 2017 | 40 | 0.030 |
Why?
|
| Prospective Studies | 2 | 2013 | 2338 | 0.030 |
Why?
|
| Cyclic AMP-Dependent Protein Kinase RIIalpha Subunit | 1 | 2017 | 8 | 0.030 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2017 | 91 | 0.030 |
Why?
|
| MAP Kinase Signaling System | 1 | 2016 | 65 | 0.030 |
Why?
|
| Action Potentials | 1 | 2017 | 186 | 0.030 |
Why?
|
| Synaptic Transmission | 1 | 2017 | 115 | 0.030 |
Why?
|
| Isometric Contraction | 1 | 2016 | 23 | 0.030 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2016 | 18 | 0.030 |
Why?
|
| Muscle Fatigue | 1 | 2016 | 13 | 0.030 |
Why?
|
| Protein Stability | 1 | 2016 | 26 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 1 | 2016 | 77 | 0.030 |
Why?
|
| Sulfonamides | 1 | 2016 | 67 | 0.030 |
Why?
|
| Protein Binding | 1 | 2016 | 201 | 0.030 |
Why?
|
| Neoplasm Metastasis | 1 | 2016 | 220 | 0.030 |
Why?
|
| Transcription, Genetic | 1 | 2016 | 134 | 0.030 |
Why?
|
| Receptors, Granulocyte Colony-Stimulating Factor | 1 | 2015 | 9 | 0.030 |
Why?
|
| Promoter Regions, Genetic | 1 | 2016 | 209 | 0.030 |
Why?
|
| Cell Nucleus | 1 | 2016 | 107 | 0.030 |
Why?
|
| Pulmonary Alveoli | 1 | 2015 | 19 | 0.030 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 1 | 2015 | 23 | 0.030 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2016 | 265 | 0.030 |
Why?
|
| Cell Line | 1 | 2016 | 436 | 0.030 |
Why?
|
| Respiratory Distress Syndrome, Adult | 1 | 2015 | 49 | 0.030 |
Why?
|
| Gene Expression Regulation | 1 | 2017 | 475 | 0.030 |
Why?
|
| Cell Proliferation | 1 | 2016 | 604 | 0.030 |
Why?
|
| Incidence | 1 | 2017 | 1246 | 0.030 |
Why?
|
| Receptors, Dopamine D3 | 1 | 2014 | 33 | 0.030 |
Why?
|
| Dogs | 1 | 2013 | 120 | 0.030 |
Why?
|
| Corpus Striatum | 1 | 2014 | 62 | 0.030 |
Why?
|
| Nucleus Accumbens | 1 | 2014 | 95 | 0.020 |
Why?
|
| Self Administration | 1 | 2014 | 293 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2013 | 308 | 0.020 |
Why?
|
| Isotonic Contraction | 1 | 2012 | 8 | 0.020 |
Why?
|
| Myofibrils | 1 | 2012 | 8 | 0.020 |
Why?
|
| Motor Activity | 1 | 2015 | 327 | 0.020 |
Why?
|
| Exercise | 1 | 2017 | 688 | 0.020 |
Why?
|
| Inflammation | 1 | 2015 | 542 | 0.020 |
Why?
|
| Middle Aged | 2 | 2017 | 12203 | 0.020 |
Why?
|
| Adipose Tissue | 1 | 2013 | 351 | 0.020 |
Why?
|
| Risk Factors | 1 | 2017 | 4001 | 0.020 |
Why?
|
| United States | 1 | 2017 | 4132 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2013 | 2287 | 0.020 |
Why?
|
| Tissue Engineering | 1 | 2013 | 659 | 0.020 |
Why?
|